AI assistant
AVACTA GROUP PLC — Share Issue/Capital Change 2015
Jan 6, 2015
7507_rns_2015-01-06_52b9e02f-ef53-4cbf-a5c5-a526bbd14718.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3456B
Avacta Group PLC
06 January 2015
Avacta Group plc
("Avacta", the "Group" or the "Company")
Issue of Equity
Avacta Group plc (AIM: AVCT), a global provider of research reagents, consumables and equipment to the life sciences and animal care markets, today announces that 7,500,000 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options.
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 January 2015.
The total number of Ordinary Shares in issue following the above issue will be 4,975,149,550 each with voting rights. No Ordinary Shares are held in Treasury.
The above figure of 4,975,149,550 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
| Avacta Group plc | www.avacta.com | |
| Alastair Smith, Chief Executive Officer | Tel: +44 (0) 844 414 0452 | |
| Tim Sykes, Chief Financial Officer | ||
| Numis Securities Limited | Tel: +44 (0) 20 7260 1000 | |
| Michael Meade / Freddie Barnfield (Nominated Adviser) | ||
| James Black (Corporate Broking) | ||
| Walbrook PR Limited | Tel: +44 (0) 20 7933 8780 or [email protected] | |
| Mike Wort | Mob: +44 (0)7900 608 002 | |
| Anna Dunphy | Mob: +44 (0)7876 741 001 | |
Avacta Group plc is a global provider of research reagents, consumables and equipment to the life sciences and animal care. Avacta operates through three divisions:
| Avacta Life Sciences www.avactalifesciences.com |
Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development. |
| Avacta Animal Health www.avactaanimalhealth.com |
Veterinary diagnostics reference laboratory services, SensiTest, and diagnostic kits, SensiPak. |
| Avacta Analytical www.avactaanalytical.com |
High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development. |
Avacta joined AIM in August 2006 and is based in Wetherby, England.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEUVVKRVAAARAR
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'X-rAz9feqvtO2rkL4AiECt7J5IIV6d_QoBIxG4uFq7utkc9wE8V1Wm1QH69ccdN6P-7Q7wu0oIeiH6KSUxm3QdmN7obFpQDXAsgNV7GKrBA1:oBUji8DiZAzFGrcUMhs-z7fGRj6wdd8aFx0j2xGdU4Wk45Kj71E2IthKBj_SD9CYtYOb-Pk2LNFjHki2qgcNGOAbnaDulZskN9LAzKGyhcc1'}});//]]>